IRVINE, Calif., April 27, 2020 (GLOBE NEWSWIRE) -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Edwards Lifesciences Corporation, the global leader in patient-focused innovations for structural heart disease and critical care monitoring, has received CE Mark for its HemoSphere advanced ...
Edwards Lifesciences Corp.'s buy of Cas Medical Systems Inc. (Casmed) this spring appears to have borne fruit. The Irvine, Calif.-based company reported that the U.S. FDA has granted clearance for a ...
Edwards Lifesciences Corporation EW has been gaining from huge potential in the Structural Heart business. The company ended the first quarter of 2022 with better-than-expected results. Strong sales ...
(Reuters) - U.S. medical device maker Edwards Lifesciences narrowly topped Wall Street estimates for quarterly revenue on Thursday as it sold more heart monitors, but its outlook for March quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results